Hwan Kim

Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells

G. Kong, Jeong-Yeon Lee, Heekyoung Chung, 2008, Breast Cancer Research and Treatment.

The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor–positive and estrogen receptor–negative human breast cancers

G. Kong, Sung-Dae Cho, Ji-Youn Jung, 2006, Molecular Cancer Therapeutics.

Protein-bound polysaccharide from Phellinus linteus induces G2/M phase arrest and apoptosis in SW480 human colon cancer cells.

Ge Li, W. Yoon, M. Na, 2004, Cancer letters.

Lactam‐Based HDAC Inhibitors for Anticancer Chemotherapy: Restoration of RUNX3 by Posttranslational Modification and Epigenetic Control

G. Han, K. Hwang, J. H. Kim, 2014, ChemMedChem.

Inhibitor of DNA Binding 1 Activates Vascular Endothelial Growth Factor through Enhancing the Stability and Activity of Hypoxia-Inducible Factor-1α

G. Kong, Jeong-Yeon Lee, Mi-Ock Lee, 2007, Molecular Cancer Research.

Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4‐ALK–Positive Human Non–Small Cell Lung Cancer

Sang Gyun Kim, S. Lim, B. Cho, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

S. Paik, S. Lim, B. Cho, 2015, Molecular Cancer Therapeutics.

EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines

Min Hwan Kim, S. Paik, S. Lim, 2016, Molecular Cancer Therapeutics.

ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.

S. Lim, B. Cho, H. Kim, 2016, Lung cancer.